These findings demonstrate that compensation for depressed NO production is sufficient to overcome Rap1 deficiency-induced endothelial dysfunction in vivo and suggests that NO is the major Rap1 effector in maintaining vessel homeostasis. This evidence concerns the gene RAP1A and endothelial dysfunction.